The takeover of the pharmaceutical company Grifols hanging by a thread. The Canadian fund Brookfield is preparing to abandon the takeover bid (takeover bid) for the Catalan listed company due to disagreements over the company’s valuation, according to Bloomberg. Last week the parties already showed their discrepancies regarding the price to be paid, since the investor had revealed that the indicative price that he valued until now was around 10.5 euros per share.
News in expansion.
#Brookfield #studies #abandoning #Grifols #takeover #bid #due #price #disagreement
.jpg?w=75&resize=75,75&ssl=1 "China will be able to reach its maximum level of coal use in 2025 thanks to the “record” increase in the use of renewable energy")
